Latham & Watkins LLP advised Owl Rock in the transaction. Arctic Wolf®, a leader in security operations, has announced the closing of a convertible notes offering...
Arctic Wolf’s $401 Million Structured Capital Financing
Pathfinder Acquisition Corporation’s Business Combination with Movella
Kirkland & Ellis advised Pathfinder Acquisition Corporation on the deal, Pillsbury Winthrop Shaw Pittman advised Movella, Latham & Watkins advised Francisco Partners. Pathfinder Acquisition Corporation (NASDAQ:...
Alphatec Spine’s $50 Million Revolving Credit Facility
Latham & Watkins represented Alphatec in the transaction. Alphatec Holdings, Inc. (Alphatec) announced the close of an asset-based revolving credit facility in the maximum aggregate amount...
EQT Private Equity’s $1.7 Billion Acquisition of Billtrust
Davis Polk advised BTRS Holdings on the deal, while Weil, Gotshal & Manges represented EQT. Latham & Watkins advised the financing sources for the transaction. BTRS...
Spectrum Pharmaceuticals’ $65 Million Debt Financing Agreement With SLR Capital Partners
Latham & Watkins represented Spectrum Pharmaceuticals in the deal. Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, has entered into...
Bottomline Technologies’ Acquisition of Nexus Systems
Latham & Watkins represented Nexus Systems in the transaction. Bottomline Technologies executed the acquisition of Nexus Systems. Terms were not disclosed. Nexus Systems, a leading provider of accounts...
Alignment Healthcare’ $250 Million Debt Financing
Latham & Watkins represented Alignment Healthcare in the transaction. Alignment Healthcare, Inc.(Alignment Healthcare) (NASDAQ: ALHC), a leading tech-enabled MedicareAdvantage company, has announced the close of an...
CommerceHub’s Acquisition of ChannelAdvisor
Cooley advised ChannelAdvisor, while Willkie Farr & Gallagher and Paul, Weiss, Rifkind, Wharton & Garrison advised CommerceHub. Kirkland & Ellis represented GTCR and Sycamore Partners and Simpson...
MeiraGTx’s Growth Financing Agreement with Perceptive Advisors
Latham & Watkins represented MeiraGTx in the transaction. MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage gene therapy company, announced a financing agreement with affiliates...
Tegus’ Acquisition of Canalyst
Tegus was advised on the transaction by teams at Latham & Watkins and Davies Ward Phillips & Vineberg. Osler, Hoskin & Harcourt LLP advised Canalyst. Tegus,...
Horizon Technology Finance Corporation’s $45 Million Growth Facility in InBrace
Latham & Watkins LLP represented InBrace in the transaction. Horizon Technology Finance Corporation (NASDAQ: HRZN) (Horizon) has announced the close of a US$45 million growth facility...
Ardelyx’s $20 Million Agreement with HealthCare Royalty Partners
Latham & Watkins represented Ardelyx, Inc. in the transaction in the transaction. Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop...